Radiology Case Reports, 2018 A 47-year-old female diagnosed with well-differentiated papillary thyroid carcinoma was referred to our center for a 131Iodine whole body scintigraphy as follow-up.
Mahdi Haghighatafshar, MD +1 more
doaj +1 more source
The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma [PDF]
, 2021 Izabela Karwacka +3 more
openalex +1 more source
Pathobiology and genetics of adrenocortical carcinoma.
Journal of Molecular Endocrinology, 2019 Adrenocortical carcinoma (ACC) is a rare malignancy with an incidence worldwide of 0.7-2.0 cases/million/year. Initial staging is the most important factor in determining prognosis.
J. Pittaway, L. Guasti
semanticscholar +1 more source
Whole-Exome Sequencing of Syndromic Adrenocortical Carcinoma Reveals Distinct Mutational Profile From Sporadic ACC [PDF]
, 2019 Norman G. Nicolson +3 more
openalex +1 more source
REVISÃO DE LITERATURA: CARCINOMA ADRENOCORTICAL (ADRENOCORTICAL CARCINOMA)
Revista de Patologia do Tocantins, 2015 O carcinoma adrenocortical é uma das lesões neoplásicas que acometem o córtex da glândula adrenal ou suprarrenal. São tumores malignos que podem ser funcionantes e secretar hormônios (cortisol, aldosterona e esteróides sexuais). Tem distribuição da faixa etária bimodal, acometendo ambos os casos.
Araujo, Julliana Negreiros de +3 more
openaire +1 more source
microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma [PDF]
, 2019 G. Kwok +7 more
openalex +1 more source
Mutated TP53 is a marker of increased VEGF expression: analysis of 7,525 pan-cancer tissues. [PDF]
, 2020 Anti-angiogenic therapies are an important class of anti-cancer treatment drugs. However, their efficacy is limited to certain tumors and would benefit from identifying a biomarker predictive of therapeutic response.
Boichard, Amélie +2 more
core
Revisiting Epidermal Growth Factor Receptor (EGFR) Amplification as a Target for Anti-EGFR Therapy: Analysis of Cell-Free Circulating Tumor DNA in Patients With Advanced Malignancies. [PDF]
, 2019 PurposeTo date, evidence for tissue epidermal growth factor receptor (EGFR) overexpression as a biomarker for anti-EGFR therapies has been weak. We investigated the genomic landscape of EGFR amplification in blood-derived cell-free tumor DNA (cfDNA ...
Fanta, Paul T +13 more
core +1 more source
Carcinoma Adrenocortical e a relação genética: uma revisão de literatura
, 2022 João Victor Carvalho da Paz +14 more
openalex +2 more sources